Porcine epidemic diarrhea virus variant strain and application thereof
By isolating and purifying the variant strain GX2506 of porcine epidemic diarrhea virus and its S gene sequence, an inactivated vaccine and ELISA kit were prepared, which solved the problem of poor control effect of existing vaccines, achieved efficient vaccine immunization and accurate antibody detection, and supported the prevention and diagnosis of porcine epidemic diarrhea virus.
Patent Information
- Application Number
- CN202610310841.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-13
- Publication Date
- 2026-06-05
AI Technical Summary
Existing PEDV vaccines are insufficient to effectively control large-scale piglet mortality caused by the G2 variant strain, and traditional isolation and culture methods are difficult, resulting in low viral titers and a lack of effective vaccines and diagnostic methods.
A variant strain of porcine epidemic diarrhea virus, GX2506, and its S gene sequence were isolated and purified to prepare an inactivated vaccine and an ELISA kit for the prevention and diagnosis of porcine epidemic diarrhea virus disease.
It has a high proliferation titer and moderate pathogenicity, and can induce high levels of neutralizing antibodies, providing effective vaccine prevention and control and accurate antibody detection, supporting the prevention and diagnosis of porcine epidemic diarrhea virus.